The Global Market for Anticoagulants (2018-2025): Analysis by Drug Class, Route of Administration and Application - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 24, 2018--The “Anticoagulants Market by Drug Class, Route of Administration, and Application, Pulmonary Embolism, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025” report has been added to ResearchAndMarkets.com’s offering.
The global anticoagulants market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025.
The global anticoagulants market is expected to grow at a significant rate during the forecast period, owing to increasing prevalence of venous thromboembolism (VTE) and cardiovascular disease across the world, growing adoption of novel oral anticoagulants (NOACs), and growing awareness of NOACs in developing regions.
Furthermore, increasing obese and geriatric population and growing demand of novel therapeutics are anticipated to further influence the market growth during the forecast period.
On the other side, higher price of NOACs and lack of antidots for NOACs impede the market growth.
Key PlayersAspen Holdings Bayer AG Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Daiichi Sankyo Company Ltd. GlaxoSmithKline PLC Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Pfizer Inc. Portola Pharmaceuticals Inc. Sanofi S.A.
Other PlayersArmetheon Inc. Astrazeneca Celgene Corporation
Key Topics Covered
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: Anticoagulants Market, by Drug Class
Chapter 5: Anticoagulants Market, by Route of Administration
Chapter 6: Anticoagulants Market, by Application
Chapter 7: Anticoagulants Market by Region
Chapter 8: Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/jlbk3s/the_global_market?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180824005121/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/24/2018 06:37 AM/DISC: 08/24/2018 06:37 AM